Cover Image

Role of Soluble FMS-Like Tyrosine Kinase (SFLT-1) /Placental Growth Factor (Plgf) Ratio as Prognostic Marker for Cases of Preeclampsia

<p><strong>Objective:</strong> The aim of this study is to identify the role of sFlt-1/PIGF ratio as a prognostic marker for cases of preeclampsia. </p><p><strong>Patients and methods:</strong> The current study is a case control study that was conducted ove...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gasser M Elbishry (Author), Ihab F Serag Eldin (Author), Ahmed A ElShahawy (Author), Gihan E Hawwary (Author), Ahmed M Riad (Author)
Format:	Book
Published:	Journal of Gynecological Research and Obstetrics - Peertechz Publications, 2017-04-15.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia
by: Ping Tang, et al.
Published: (2017)

Differences in levelFms-Like Tyrosine Kinase-1 (sFlt-1), soluble Endoglin (s-Eng), and Placental Growth Factor (PIGF) between Early Onset Preeclampsia and Late Onset Preeclampsia
by: Lita Nafratilova, et al.
Published: (2018)

Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
by: Laura Ehrlich, et al.
Published: (2017)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
by: Vorapong Phupong, et al.
Published: (2020)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
by: Carmen Rădulescu, et al.
Published: (2016)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
by: Meron M. Kifle, et al.
Published: (2022)

An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia
by: Mahmoud Fathy Hassan, et al.
Published: (2013)

A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk
by: Cristian Nicolae Chirilă, et al.
Published: (2024)

Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study
by: Ahmed M. Abbas, et al.
Published: (2018)

Soyghurt Potentially Controls the Level of sFlt1 and PLGF in Preeclampsia Maternal Serum-Induced Placental Trophoblast Cell in vitro
by: Khairani AF, et al.
Published: (2024)

PlGF, sFlt-1 and sFlt-1/PlGF ratio: Promising markers for predicting pre-eclampsia
by: Ola H El-Demerdash, et al.
Published: (2018)

Differentiating Maternal Angiogenesis Factors between Early and Late Onset Preeclampsia: Higher sflt-1 in Early Onset Preeclampsia, Lower PlGF and Higher sflt-1/PlGF Ratio in Late Onset Preeclampsia
by: Joserizal Serudji, et al.
Published: (2024)

Differences Ratio Level Soluble FMS-Like Tyrosine Kinase-1 and Placental Growth Factor Early And Late Onset on Preeclampsia and Normal Pregnancy
by: Ria Andina, et al.
Published: (2018)

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies
by: Alice Hoeller, et al.
Published: (2017)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
by: Pooneh Nikuei, et al.
Published: (2020)

Predictive Value Analysis of Serum sFlt-1 and PLGF Levels/Ratio in Preeclampsia
by: Shuyuan Xue, et al.
Published: (2022)

Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy
by: Muhammad Ilham Aldika Akbar, et al.
Published: (2018)

Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort
by: A. Iannaccone, et al.
Published: (2022)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
by: Risa Miyatake, et al.
Published: (2023)

sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
by: Kamil Pluta, et al.
Published: (2024)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
by: Dietmar Schlembach, et al.
Published: (2018)

A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
by: Guili Chen, et al.
Published: (2024)

Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study
by: Satoshi Shinohara, et al.
Published: (2021)

Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction
by: Vesna Fabjan-Vodusek, et al.
Published: (2019)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
by: Namrata Kumar, MD, MRCOG, EFOG, FACOG, et al.
Published: (2023)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
by: Vivek Pant, et al.
Published: (2019)

Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?
by: Majed Alhudhud, et al.
Published: (2024)

Associations between Maternal sFlt-1/PlGF Ratio and Perinatal and Neonatal Outcomes in Newborns Born to Mothers with Preeclampsia
by: Hyo Ju Yang, et al.
Published: (2023)

Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
by: Ai-ris Yonekura Collier, et al.
Published: (2019)

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy
by: Alaa Raeed, et al.
Published: (2024)

Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy-associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1-placental growth factor ratio in the early second trimesterAJOG Global Reports at a Glance
by: Tianhua Huang, PhD, et al.
Published: (2023)

Angiogenic factors (sFlt-1, PlGF) in twin pregnancy with placentaassociated complications
by: M. A. Kurtser, et al.
Published: (2022)

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
by: Catherine Primo Nogueira de Sá, et al.
Published: (2020)

sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive statusAJOG Global Reports at a Glance
by: Easha Patel, MD, et al.
Published: (2024)

Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study
by: Teresa M. MacDonald, et al.
Published: (2018)

Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
by: Park So-Yeon, et al.
Published: (2008)

Análisis económico del cociente de preeclampsia sFlt- 1/PlGF comparado con el estándar de atención en Uruguay
by: Gonzalo Guiñazú, et al.
Published: (2024)

The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes
by: Yu-Shan Chang, et al.
Published: (2017)

Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction
by: Satoshi Shinohara, et al.
Published: (2017)

Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review
by: Hadfield Ruth, et al.
Published: (2011)